Key Financial’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
Other funds holding LTRN
CM
Key Financial's LTRN Position: Q3 2026 in Review
Key Financial held its Lantern Pharma (LTRN) position steady in Q3 2026 at 2 shares worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #1311.
Key Financial first reported a position in LTRN in Q2 2025 and has held it in 6 quarters since. The position peaked at $8 in Q2 2026. 36 funds tracked by Wall St. Rank hold LTRN as of Q3 2026.
- Key Financial held 2 shares of Lantern Pharma worth $2 as of Q3 2026.
- Key Financial left its Lantern Pharma share count unchanged in Q3 2026.
- Lantern Pharma made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1311 holding.
- Key Financial first reported a position in Lantern Pharma in Q2 2025 and has held it in 6 quarters since.
- Key Financial's Lantern Pharma position peaked at $8 in Q2 2026.
- 36 funds tracked by Wall St. Rank held Lantern Pharma as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.